← All Sponsors
SPONSOR

Vanderbilt University Medical Center

Total Trials
18
Recruiting
18
Phases
EARLY_Phase 1, Phase 2, Phase 1

Vanderbilt University Medical Center is a clinical research sponsor with 18 registered studies on ClinicalTrials.gov, of which 18 are actively recruiting participants. Research covers conditions including Type 1 Diabetes, Down Syndrome, Down Syndrome, Partial Trisomy 21, Alzheimer Disease.

The trial portfolio spans EARLY_Phase 1, Phase 2, Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — Vanderbilt University Medical Center

How many clinical trials has Vanderbilt University Medical Center sponsored?
ClinicalMetric currently tracks 18 clinical trials sponsored by Vanderbilt University Medical Center, of which 18 are actively recruiting participants. These trials cover conditions including Type 1 Diabetes, Down Syndrome, Down Syndrome, Partial Trisomy 21. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Vanderbilt University Medical Center research focus on?
Vanderbilt University Medical Center clinical trials span Type 1 Diabetes, Down Syndrome, Down Syndrome, Partial Trisomy 21, Alzheimer Disease, Physician, and additional conditions. The research pipeline includes EARLY_Phase 1, Phase 2, Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Vanderbilt University Medical Center clinical trial?
To participate in a Vanderbilt University Medical Center trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Vanderbilt University Medical Center trials with current recruitment status updated daily.

Clinical Trials by Vanderbilt University Medical Center

NCT06338553 EARLY_Phase 1
Recruiting

GLP-1Ra Impact on Metabolic Outcomes in Stage 2 T1DM While Receiving Teplizumab

Type 1 Diabetes
NCT05231798 Phase 2
Recruiting

Cholinergic Integrity in Down Syndrome in Association With Aging, Alzheimer's Disease Pathology, and Cognition

Down Syndrome
NCT07686211
Recruiting

Deformable Tissue Modelling and Augmented Reality Based Guidance for Head and Neck Tumor Re-Resection Task

Physician
NCT07467980
Recruiting

Endoscopic COlorectal Mucosal Evaluation of Oxygen Tension

Anastomotic Leak Rectum
NCT06549452
Recruiting

Mobile Health Intervention to Improve Exercise in Pediatric PH

Pulmonary Arterial Hypertension
NCT00575081
Recruiting

Physiological Brain Atlas Development

Parkinson's Disease
NCT05774717 Phase 1
Recruiting

Tranexamic Acid in Rhinoplasty: Perioperative Bleeding, Edema and Ecchymosis

Surgery
NCT06609356 EARLY_Phase 1
Recruiting

Cardiometabolic Benefit of Reducing Iatrogenic Hyperinsulinemia Using Insulin Adjunctive Therapy in Type 1 Diabetes

Type 1 Diabetes Mellitus
NCT06002477 EARLY_Phase 1
Recruiting

Attentional Mechanisms in SCD

Subjective Cognitive Decline
NCT06516614
Recruiting

Sleep Coach for Adolescents With Type 1 Diabetes

Type 1 Diabetes
NCT06483854
Recruiting

Healer-initiated HIV Counseling and Testing Versus Standard of Care in Rural South Africa

Hiv
NCT03042988
Recruiting

Overnight Trials With Heat Stress in Autonomic Failure Patients With Supine Hypertension

Hypertension
NCT07457489
Recruiting

Vanderbilt Integrated Community TMS for Opioid Recovery

Opiod Use Disorder
NCT07529691
Recruiting

Survey on Physical Activity and Qualify of Life in Fibromuscular Dysplasia

Fibromuscular Dysplasia of Arteries
NCT07225543 Phase 2
Recruiting

2-HOBA in Systemic Lupus Erythematosus

Systemic Lupus Erthematosus (SLE)
NCT02897063 Phase 1
Recruiting

Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure

Autonomic Failure
NCT06939803
Recruiting

AI-driven Clinical Decision Support to Reduce Hospital-Acquired Venous Thromboembolism: Study Protocol for the VTE-AI Randomized Trial.

Venothromboembolism
NCT06124196
Recruiting

Wearable Technology to Evaluate Hyperglycemia and HRV in DMD

Duchenne Muscular Dystrophy
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology